{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:40:13Z","timestamp":1780540813943,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.transproceed.2008.10.019","type":"journal-article","created":{"date-parts":[[2008,12,21]],"date-time":"2008-12-21T10:50:55Z","timestamp":1229856655000},"page":"S17-S20","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S","title":["Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine"],"prefix":"10.1016","volume":"40","author":[{"given":"B.D.","family":"Kahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.10.019_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1749-6632.1962.tb45358.x","article-title":"A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs","volume":"99","author":"Calne","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.transproceed.2008.10.019_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1353\/pbm.1994.0094","article-title":"France and the early history of organ transplantation","volume":"37","author":"Starzl","year":"1993","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.transproceed.2008.10.019_bib3","first-page":"175","article-title":"Two paradigms for new immunosuppressive strategies in organ transplantation","volume":"3","author":"Hong","year":"1998","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2008.10.019_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00007890-199101000-00038","article-title":"Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro","volume":"51","author":"Kahan","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00007890-199101000-00002","article-title":"Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat","volume":"51","author":"Stepkowski","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ki.1996.28","article-title":"The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplantpatients","volume":"49","author":"Murgia","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2008.10.019_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","article-title":"Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial","volume":"68","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2008.10.019_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide Phase III randomized, controlled safety and efficacy study of a sirolimus-cyclosporine regimen","volume":"71","author":"McDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib11","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0041-1345(03)00353-1","article-title":"Two-year results of multicenter phase III trials on the effect of addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.10.019_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1067\/mcp.2001.116309","article-title":"Median effect analysis of efficacy versus adverse effects of immunosuppressants","volume":"70","author":"Kahan","year":"2001","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.transproceed.2008.10.019_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e318187bab0","article-title":"Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: Results from an open-label, randomized trial","author":"Gaber","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"issue":"Suppl","key":"10.1016\/j.transproceed.2008.10.019_bib15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.transproceed.2008.10.003","article-title":"Addressing the challenges for improving long term outcomes in renal transplantation","volume":"40","author":"Chapman","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.10.019_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0041-1345(00)02473-8","article-title":"Sirolimus permits steroid withdrawal from a cyclosporine regimen","volume":"33","author":"Mahalati","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.10.019_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0041-1345(03)00351-8","article-title":"Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.10.019_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.TP.0000173770.42403.F7","article-title":"Low incidence of malignancies among cyclosporine-sirolimus treated renal transplant recipients","volume":"80","author":"Kahan","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with Target-of-Rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.tp.0000268524.27506.39","article-title":"BK virus associated nephropathy in sirolimus-treated renal transplant patients","volume":"84","author":"Benavides","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200110150-00011","article-title":"Effect of sirolimus on the metabolism of apoB100-containing lipoproteins in renal transplant patients","volume":"72","author":"Hoogeveen","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels and fatty acid metabolism in renal transplant patients","volume":"43","author":"Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.transproceed.2008.10.019_bib23","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.transproceed.2007.10.008","article-title":"Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen","volume":"39","author":"Lisik","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.10.019_bib24","first-page":"224","article-title":"Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification","volume":"53","author":"Knight","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib25","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/00007890-200005270-00019","article-title":"Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: Risk factors, incidence, progression, and management","volume":"69","author":"Hong","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.10.019_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00007890-200209270-00012","article-title":"Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients","volume":"74","author":"Langer","year":"2002","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508014413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508014413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:41:05Z","timestamp":1589416865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508014413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0041134508014413"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.10.019","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}